distal jejunal-release dextrose (APHD-012)
/ Aphaia Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 10
Of
10
Go to page
1
September 17, 2025
A Study to Investigate the Efficacy and Safety of Two Different Doses of Twice Daily Distal Jejunal-release Dextrose Beads Formulations Combined With a Gel Composition Compared to Placebos in Obese Subjects With Weight Related Comorbidities
(clinicaltrials.gov)
- P2 | N=102 | Recruiting | Sponsor: Aphaia Pharma US LLC | Trial completion date: Mar 2026 ➔ Jul 2026 | Trial primary completion date: Mar 2026 ➔ Jul 2026 | Not yet recruiting ➔ Recruiting
Enrollment open • Trial completion date • Trial primary completion date • Obesity
September 09, 2025
Aphaia Pharma Initiates Second Phase 2 Trial of Oral Candidate in Obesity
(GlobeNewswire)
- "'While we await the finalization of the second Phase 2 trial—anticipated in mid-2026...'"
New P2 trial • Trial status • Obesity
June 06, 2025
A Study to Investigate the Efficacy and Safety of Two Different Doses of Twice Daily Distal Jejunal-release Dextrose Beads Formulations Combined With a Gel Composition Compared to Placebos in Obese Subjects With Weight Related Comorbidities
(clinicaltrials.gov)
- P2 | N=102 | Not yet recruiting | Sponsor: Aphaia Pharma US LLC
New P2 trial • Obesity
October 16, 2024
A Study of Distal Jejunal-release Dextrose in Obese Participants
(clinicaltrials.gov)
- P2 | N=150 | Active, not recruiting | Sponsor: Aphaia Pharma US LLC | Recruiting ➔ Active, not recruiting | Trial completion date: Mar 2024 ➔ Nov 2024 | Trial primary completion date: Mar 2024 ➔ Nov 2024
Enrollment closed • Trial completion date • Trial primary completion date • Obesity
October 16, 2024
A Study to Evaluate Efficacy and Safety of Distal Jejunal-release Dextrose Beads Formulation in Subjects With a Pathological Oral Glucose Tolerance Test
(clinicaltrials.gov)
- P2 | N=31 | Completed | Sponsor: Aphaia Pharma US LLC | Recruiting ➔ Completed | Trial completion date: Oct 2023 ➔ Feb 2024 | Trial primary completion date: Oct 2023 ➔ Feb 2024
Trial completion • Trial completion date • Trial primary completion date • Metabolic Disorders
July 06, 2023
A Study to Evaluate Efficacy and Safety of Distal Jejunal-release Dextrose Beads Formulation (APHD-012) in Subjects With a Pathological Oral Glucose Tolerance Test (OGTT)
(clinicaltrials.gov)
- P2 | N=30 | Recruiting | Sponsor: Aphaia Pharma US LLC | Not yet recruiting ➔ Recruiting
Enrollment open • Metabolic Disorders
April 07, 2023
A Study to Evaluate Efficacy and Safety of Distal Jejunal-release Dextrose Beads Formulation (APHD-012) in Subjects With a Pathological Oral Glucose Tolerance Test (OGTT)
(clinicaltrials.gov)
- P2 | N=30 | Not yet recruiting | Sponsor: Aphaia Pharma US LLC
New P2 trial • Metabolic Disorders
February 21, 2023
Pharmacodynamics and Pharmacokinetics of Different Glucose Bead Formulations in Obese Healthy Subjects
(clinicaltrials.gov)
- P1 | N=20 | Completed | Sponsor: Aphaia Pharma US LLC
New P1 trial • Obesity
January 11, 2023
A Study of Distal Jejunal-release Dextrose in Obese Participants
(clinicaltrials.gov)
- P2 | N=150 | Recruiting | Sponsor: Aphaia Pharma US LLC | Not yet recruiting ➔ Recruiting | Trial completion date: Jul 2023 ➔ Mar 2024 | Trial primary completion date: Jul 2023 ➔ Mar 2024
Enrollment open • Trial completion date • Trial primary completion date • Obesity
May 23, 2022
A Study of Distal Jejunal-release Dextrose in Obese Participants
(clinicaltrials.gov)
- P2 | N=150 | Not yet recruiting | Sponsor: Aphaia Pharma US LLC
New P2 trial • Obesity
1 to 10
Of
10
Go to page
1